Joe Green

Venture capitalist and businessman Stephen Jurvetson is joining an expanding group of prominent investors who are backing research into psychedelic ventures. Last week, Jurvetson spoke at the New York City conference “Horizons: Perspectives on Psychedelics” on the...

In a welcomed throwback to the days before psychedelic use and research was considered a forbidden topic, the conference “Horizons: Perspectives On Psychedelics” in New York City is an incredible testimony to where the field of psychedelic therapy, and the industry as a whole, is...

The Multidisciplinary Association for Psychedelic Studies, a non-profit working to legalize the psychedelic MDMA for assisted psychotherapy, announced Thursday that it has raised the $30 million necessary to complete phase 3 trials and achieve FDA approval for the drug. The Capstone Challenge,...